Cargando…
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number of already approved and marketed drugs are being tested for repurposing, including Favipiravir. We aim to investigate the efficacy and safety of Favipiravir i...
Autores principales: | Hassanipour, Soheil, Arab-Zozani, Morteza, Amani, Bahman, Heidarzad, Forough, Fathalipour, Mohammad, Martinez-de-Hoyo, Rudolph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155021/ https://www.ncbi.nlm.nih.gov/pubmed/34040117 http://dx.doi.org/10.1038/s41598-021-90551-6 |
Ejemplares similares
-
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
por: Hassanipour, Soheil, et al.
Publicado: (2022) -
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
por: Arab-Zozani, Morteza, et al.
Publicado: (2020) -
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
por: Hassaniazad, Mehdi, et al.
Publicado: (2020) -
Epidemiologic Profile of Microscopic Hematuria in Iran: A Systematic Review and Meta-Analysis
por: Khosousi, Mohammad-Javad, et al.
Publicado: (2022) -
Following PRISMA in a Systematic Review: Obligation or Authority?
por: Arab-Zozani, Morteza, et al.
Publicado: (2020)